Recall Weekly← all recalls
FDA-PR2026-07-24PACKAGING DEFECT

Baxter Cefazolin in Dextrose Injection recalled for cardboard particles in solution

Baxter
Nationwide distribution

Baxter Cefazolin Dextrose Injection recalled for particulate contamination

Baxter is recalling one lot of Cefazolin in Dextrose Injection (a frozen antibiotic infusion bag) because cardboard particles were found in the solution. The affected lot (LD175708, expiring February 14, 2027) was distributed between March and June 2025. No injuries have been reported so far.

  • If you use or administer this medication, check the lot number and expiration date on your package.
  • Stop using the product immediately if you have the affected lot.
  • Return all affected units to your pharmacy or healthcare facility following your facility's standard process.
  • Contact Baxter Healthcare Center for Service at 888-229-0001 (7 am–6 pm CT, weekdays) with questions.
  • Report any adverse reactions to FDA MedWatch at www.fda.gov/medwatch or 1-800-332-1088.

Product photos

Cefazolin in Dextrose Injection USP IV bag with a red circle highlighting the lot number and expiration date
Cefazolin in Dextrose Injection USP IV bag with a red circle highlighting the lot number and expiration date
Close-up of the Cefazolin in Dextrose Injection USP IV bag showing the lot number and expiration date inside a red box.
Close-up of the Cefazolin in Dextrose Injection USP IV bag showing the lot number and expiration date inside a red box.
Cefazolin in Dextrose Injection USP box with a red circle highlighting the lot number and expiration date on the side label.
Cefazolin in Dextrose Injection USP box with a red circle highlighting the lot number and expiration date on the side label.
Hazard

July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.<br> Risk Statement: The use of the defective product has a

Official notice

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-voluntary-nationwide-recall-cefazolin-dextrose-injection-usp-2g-100ml-20mg-ml-single

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief